retatrutide obesity clinical trial results Biggest news 🚨 TRIUMPH-1 are here: Retatrutide's phase 3 showed up to 28% average weight loss over 80 weeks — with nearly half of patients losing over 30% of Retatrutide TRIUMPH-1 Results: 28% Weight

A landmark paper in 2021 describes patients taking 2.4mg (the maximum dose of Wegovy) for 68 weeks, and yielding sustained, clinically relevant weight loss of up to 15%

Wegovy currently warns it may cause serious side effects including conditions such as thyroid tumors, pancreatitis, gallbladder problems, depression and severe stomach problems. There is nothing thats really all benefit and no risk. McClains suit is among the latest to join about 3,200 federal challenges, which are in addition to more than 1,200 lawsuits against Novo Nordisk and Eli Lilly in state courts in New Jersey, Indiana and Delaware

and (4) outcome data, including incidence rates of depression and other psychiatric events, changes in metabolic parameters (body weight, BMI, fasting blood glucose, and lipid profiles), and loss to follow-up information (proportion, timing, and reasons)

Some patients experienced noticeable results, such as brighter skin and improved clarity

Certain fermented foods containing probiotics, such as kefir, sauerkraut, kimchi, and live yoghurt, may indirectly influence GLP-1 production by promoting a healthy gut microbiome